Department of Cancer Physiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida 33612, USA.
Division of Pulmonary and Critical Care Medicine, David Geffen School of Medicine at the University of California, Los Angeles, California 90095, USA.
Cold Spring Harb Perspect Med. 2021 Nov 1;11(11):a037838. doi: 10.1101/cshperspect.a037838.
Lung cancer is a heterogeneous disease that is subdivided into histopathological subtypes with distinct behaviors. Each subtype is characterized by distinct features and molecular alterations that influence tumor metabolism. Alterations in tumor metabolism can be exploited by imaging modalities that use metabolite tracers for the detection and characterization of tumors. Microenvironmental factors, including nutrient and oxygen availability and the presence of stromal cells, are a critical influence on tumor metabolism. Recent technological advances facilitate the direct evaluation of metabolic alterations in patient tumors in this complex microenvironment. In addition, molecular alterations directly influence tumor cell metabolism and metabolic dependencies that influence response to therapy. Current therapeutic approaches to target tumor metabolism are currently being developed and translated into the clinic for patient therapy.
肺癌是一种异质性疾病,可分为具有不同行为特征的组织病理学亚型。每种亚型都具有独特的特征和分子改变,这些改变会影响肿瘤的代谢。可以利用代谢物示踪剂来检测和描述肿瘤的成像方式来利用肿瘤代谢的改变。微环境因素,包括营养和氧气的供应以及基质细胞的存在,对肿瘤代谢有重要影响。最近的技术进步促进了在这个复杂的微环境中直接评估患者肿瘤的代谢改变。此外,分子改变直接影响肿瘤细胞代谢和影响治疗反应的代谢依赖性。目前正在开发针对肿瘤代谢的治疗方法,并将其转化为临床患者治疗。